Clinical trial

A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease

NCT00235716 · US Department of Veterans Affairs, U.S. Fed · Completed

Key facts

NCT number NCT00235716
Title A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease
Official title CSP #546 - A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease (TEAM-AD)
Acronym TEAM-AD
Lead sponsor US Department of Veterans Affairs, U.S. Fed
Collaborators Forest Laboratories Industry DSM Nutritional Products, Inc.
Status Completed
Phase Phase 3
Study type Interventional
Conditions Alzheimer's Disease
Intervention type Drug
Interventions dl-alpha-tocopherol, Memantine, Placebo
Enrollment 613
Start date Aug 1, 2007
Primary completion Sep 1, 2012
Completion Oct 1, 2012
First posted Oct 10, 2005
Last update posted Jul 23, 2014
Countries Puerto Rico, United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies